Drug Trial Radar · NCT05509023
Evaluating Safety and Efficacy of ADX-914 in Patients With Moderate to Severe Atopic Dermatitis (SIGNAL-AD)
Last checked: Nov 19, 2026Latest source record: Oct 3, 2024 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Active, not recruiting
Enrollment
102
Planned (sponsor's estimate)
Start
Sep 30, 2022
Primary completion
Dec 2024
Study completion Dec 2024
Sponsor
- Lead sponsor
- Q32 Bio Inc.Industry
- Sponsor type
- Industry
- First posted
- Aug 19, 2022
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Triple (participant, care provider, investigator)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This is a phase IIa, randomized, double-blind, placebo-controlled, multi-center proof-of-concept (POC) study in subjects with moderate to severe Atopic Dermatitis.
Conditions
- Atopic Dermatitis
Interventions
ADX-914Drug
Subcutaneous administration of ADX-914
PlaceboDrug
Subcutaneous administration of Placebo
Primary outcomes
What the sponsor says the trial is designed to measure.
- Part A only: Safety parameters including incidence of serious adverse events and adverse events of special interestTime frame: 14 Weeks
- Part A and B: Mean percentage change from baseline in Eczema Area and Severity Index (EASI) score at Week 14 for ADX-914 vs placeboTime frame: 14 Weeks
Locations
24 sites in 1 country. Site status is shown where the registry gives one.
Cahaba Dermatology Skin Health Center
Birmingham, Alabama
First OC Dermatology
Fountain Valley, California
California Allergy and Asthma Medical Group- Los Angeles
Los Angeles, California
Integrative Skin Science and Research
Sacramento, California
Dermatology Institute and Skin Care Center
Santa Monica, California
Torrance Clinical Research Institute Inc.
Torrance, California
Integrated Research of Inland, Inc.
Upland, California
RM Medical Research Inc.
Homestead, Florida
Medical Research Center of Miami
Miami, Florida
Well Pharma Medical Research Corporation
Miami, Florida
GCP Research
St. Petersburg, Florida
Advanced Medical Research, PC
Sandy Springs, Georgia
Treasure Valley Medical Research
Boise, Idaho
Sneeze wheeze and Itch Associates LLC
Normal, Illinois
Southern Indiana Clinical Trials
New Albany, Indiana
Visage Clinical Research
Largo, Maryland
Revival Research Corporation- Clinedge
Troy, Michigan
Apex Clinical Research Center
Painesville, Ohio
Clinical Partners, LLC
Johnston, Rhode Island
North Texas Center for Clinical Research
Frisco, Texas
Progressive Clinical Research
San Antonio, Texas
JBR Clinical Research
Salt Lake City, Utah
Dermatology of Seattle & Bellevue
Seattle, Washington
Dermatology Specialists of Spokane
Spokane, Washington
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.